REFERENCES
- Wilkie WL, Moore ES. Marketing's contributions to society. J Marketing. 1999; 63(Special Issue):198-218. (reprinted in this issue of JPMM on pp. 11–56)
- Healthcare: Pharmaceuticals. Standard and Poor's Industry Surveys. New York: Standard and Poor's Corp.; December 16, 1999.
- IMS Health Incorporated [resource on World Wide Web]. URL: http://www. imshealth.com/public/structure/dispcontent/1,2779,1000-1000-111787,00.html. Avail-able from Internet. Accessed 2001 Apr 5.
- Healthcare: Pharmaceuticals. Standard and Poor's Industry Surveys. New York: Standard and Poor's Corp.; December 21, 2000.
- NWDA. National Wholesale Druggists' Association [resource on World Wide Web]. URL: http://www.nwda.org/infobase/. Available from Internet. Accessed 2000 Nov 1.
- Levy R, Smith M. Pharmaceutical marketing: Linking therapy to patient needs. Reston, VA: National Pharmaceutical Council; 1993.
- Frank SR. Digital health care-the convergence of health care and the Internet. J Ambulatory Care Manage. 2000; 23(2):8–17.
- Lasagna L. Recent trends in drug development. In: The inside story of medi-cines: A symposium. Higby GJ, Stroud EC, eds. Madison, WI: American Institute of the History of Pharmacy; 1997:217–22.
- Kramer PD. Listening to Prozac. New York: Penguin Books; 1997.
- NCPA. National Community Pharmacists Association [resource on World Wide Web]. URL: http://www.ncpanet.org/ABOUTNCPA/today.html. Available from Internet. Accessed 2000 Nov 1.
- Hemminki E. Review of literature on the factors affecting drug prescribing. Soc Sci Med. 1975; 9:111–16.
- Avorn J, Harvey K, Soumerai SB, Herxheimer A, Plumridge R, Bardelay G. In-formation and education as determinants of antibiotic use: Report of Task Force 5. Rev Infect Dis. 1987; 9(Suppl 3):s286–s296.
- Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982; 73:4–8.
- Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach: A randomized controlled trial of academically based "detailing." N Engl J Med. 1983; 308:1457–63.
- Rubin PH. Economics of prescription drug advertising. J Res Pharm Econ. 1991; 3(4):29–39.